FDA warns on Pfizer&#39;s Bextra
449178
US regulators warned yesterday of possible heart risks with Pfizer&#39;s Bextra, delivering another blow to popular pain drugs cox-2 inhibitors such as Vioxx, withdrawn from the market by Merck in September.
557597
Oct. 15, 2004 -- Bextra -- one of two US approved Vioxx sister drugs -- may cause rare skin and heart side effects, its manufacturer today warned doctors.
33279
The federal Food and Drug Administration approved new labeling Thursday for Pfizer Inc.&#39;s Bextra drug to warn of possible serious skin reactions and heart-related problems for those who&#39;ve experienced coronary bypass surgery.
141451
SINGAPORE : Doctors in the United States have warned that painkillers Bextra and Celebrex may be linked to major cardiovascular problems and should not be prescribed.
479491
Drugmaker Pfizer said Friday that its Bextra drug, seen as an alternative to Merck&#39;s Vioxx arthritis medication, may raise heart risk in high-risk bypass surgery patients.
352014
Pfizer Inc. will warn doctors that its Bextra painkiller, which is in the same group of drugs as Merck &amp; Co.&#39;s withdrawn Vioxx, is linked to an elevated risk of blood clots, heart attacks and strokes in cardiac-surgery patients.
130323
BEIJING, Dec. 24 -- FDA has recommended on Thursday that doctors and users are cautious to use the controversial painkillers -- Pfizer Inc.
266677
OTTAWA - Health Canada is warning people about heart and skin problems associated with the painkiller Bextra. Bextra (valdecoxib), which is used to treat arthritis and menstrual pain, belongs to a class of
19437
Recent studies have suggested that Celebrex and Bextra may increase the risk of heart attack and stroke.
402524
New York - Pfizer, the world&#39;s largest drug maker, is discussing with US regulators whether to add a stronger warning to its Bextra painkiller about rare, serious skin reactions.
153246
More evidence of how painkillers  called COX-2 inhibitors can raise the risk of heart disease was  published Monday, showing Pfizer Inc.'s Bextra can triple the  risk of heart attack and stroke in certain patients.
440218
Pfizer Inc. on Wednesday defended  its arthritis drug Bextra after a prominent cardiologist said a  pooled analysis of clinical trial results showed patients  taking the drug were twice as likely to have a heart attack or  stroke as those taking a placebo.
561495
Dec. 19--Pfizer, the world&#39;s biggest drug maker, and the rest of the pharmaceutical sector will come under renewed pressure this week after the Food and Drug Administration (FDA) warned doctors to consider
102866
A study suggesting arthritis drug Bextra doubles patients&#39; heart attack and stroke risks drew a sharp rebuttal Wednesday from the drug&#39;s maker, Pfizer (PFE), as its stock price dipped.
729940
NEW YORK, OCTOBER 15 : PFIZER Inc. on Friday said two clinical trials showed patients taking its anti-inflammatory drug Bextra, had a higher risk of cardio-vascular events during high-risk coronary bypass surgery.
365287
Kaiser Permanente has stopped dispensing Bextra, an arthritis and pain drug made by Pfizer that may increase the risk of heart attacks and strokes.
422988
The withdrawal of Vioxx from the market in September and more recent concerns about its cousin Bextra have raised safety questions about this entire class of painkillers